June 18, 2024 02:36 PM EDT

Teva and US government discuss settling kickback lawsuit over Copaxone

Katherine Lewin

News Reporter

Teva and the US government are in talks to settle a lawsuit against the company alleging a kickback scheme for its blockbuster multiple sclerosis drug …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Teva and US government discuss settling kickback lawsuit over Copaxone

Katherine Lewin

News Reporter

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Steve Davis leaves Acadia, replaced by Bristol Myers alum; Former J&J exec to lead R&D at Novavax

Novo Nordisk to decrease some insulin pen manufacturing, transition supply

The Endpoints 11 winners: Big bets on AI, new frontiers in editing, a neuro renaissance and Chinese chemistry

WeightWatchers replaces CEO who spearheaded its push into prescription weight loss drugs

US government renews threats over J&J's proposed 340B rebate model

PDCs vs. ADCs: A New Frontier in Targeted Cancer Therapies and the Potential for Development Partnerships

Te­va and US gov­ern­ment dis­cuss set­tling kick­back law­suit over Co­pax­one

News Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Teva and US government discuss settling kickback lawsuit over Copaxone